Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C24H35FO6 |
| Molecular Weight | 438.5295 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 9 / 9 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC1(C)O[C@@H]2C[C@H]3[C@@H]4CC[C@H]5CC(=O)CC[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)CO
InChI
InChIKey=GZBONOYGBJSTHF-QLRNAMTQSA-N
InChI=1S/C24H35FO6/c1-20(2)30-19-10-16-15-6-5-13-9-14(27)7-8-21(13,3)23(15,25)17(28)11-22(16,4)24(19,31-20)18(29)12-26/h13,15-17,19,26,28H,5-12H2,1-4H3/t13-,15-,16-,17-,19+,21-,22-,23-,24+/m0/s1
| Molecular Formula | C24H35FO6 |
| Molecular Weight | 438.5295 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 9 / 9 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Drocinonide is a synthetic glucocorticoid used as anti-inflammatory agent. It was shown that drocinonide phosphate potassium is effective ocular anti-inflammatory agent that does not show a strong tendency to elevate the intra-ocular pressure. Drocinonide phosphate potassium forms an insoluble complex with neomycin sulfate in aqueous solution. Dibasic sodium phosphate can be employed in an ophthalmic formulation to prevent the formation of this precipitate without affecting the stability of the steroid or the bioactivity of the antibiotic.
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Wed Apr 02 09:49:51 GMT 2025
by
admin
on
Wed Apr 02 09:49:51 GMT 2025
|
| Record UNII |
6UJ1P9T59P
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
Drocinonide
Created by
admin on Wed Apr 02 09:49:51 GMT 2025 , Edited by admin on Wed Apr 02 09:49:51 GMT 2025
|
PRIMARY | |||
|
3394
Created by
admin on Wed Apr 02 09:49:51 GMT 2025 , Edited by admin on Wed Apr 02 09:49:51 GMT 2025
|
PRIMARY | |||
|
CHEMBL2104454
Created by
admin on Wed Apr 02 09:49:51 GMT 2025 , Edited by admin on Wed Apr 02 09:49:51 GMT 2025
|
PRIMARY | |||
|
2355-59-1
Created by
admin on Wed Apr 02 09:49:51 GMT 2025 , Edited by admin on Wed Apr 02 09:49:51 GMT 2025
|
PRIMARY | |||
|
20055479
Created by
admin on Wed Apr 02 09:49:51 GMT 2025 , Edited by admin on Wed Apr 02 09:49:51 GMT 2025
|
PRIMARY | |||
|
6UJ1P9T59P
Created by
admin on Wed Apr 02 09:49:51 GMT 2025 , Edited by admin on Wed Apr 02 09:49:51 GMT 2025
|
PRIMARY | |||
|
36637-22-6
Created by
admin on Wed Apr 02 09:49:51 GMT 2025 , Edited by admin on Wed Apr 02 09:49:51 GMT 2025
|
SUPERSEDED | |||
|
DTXSID101043234
Created by
admin on Wed Apr 02 09:49:51 GMT 2025 , Edited by admin on Wed Apr 02 09:49:51 GMT 2025
|
PRIMARY | |||
|
SUB06402MIG
Created by
admin on Wed Apr 02 09:49:51 GMT 2025 , Edited by admin on Wed Apr 02 09:49:51 GMT 2025
|
PRIMARY | |||
|
219-093-6
Created by
admin on Wed Apr 02 09:49:51 GMT 2025 , Edited by admin on Wed Apr 02 09:49:51 GMT 2025
|
PRIMARY | |||
|
C166963
Created by
admin on Wed Apr 02 09:49:51 GMT 2025 , Edited by admin on Wed Apr 02 09:49:51 GMT 2025
|
PRIMARY | |||
|
100000080800
Created by
admin on Wed Apr 02 09:49:51 GMT 2025 , Edited by admin on Wed Apr 02 09:49:51 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |